Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,662 | 212,803 | 19,205 | 17,152 | 33,703 |
| Marketable Securities | 631,631 | 438,960 | 324,823 | 332,560 | 269,586 |
| Receivables | 7,500 | 519 | N/A | N/A | N/A |
| TOTAL | $661,939 | $658,666 | $349,241 | $355,195 | $309,302 |
| Non-Current Assets | |||||
| PPE Net | 5,940 | 6,517 | 7,003 | 7,317 | 7,378 |
| Other Non-Current Assets | 23,533 | 23,801 | 24,163 | 24,338 | 24,820 |
| TOTAL | $29,473 | $30,318 | $31,166 | $31,655 | $32,198 |
| Total Assets | $691,412 | $688,984 | $380,407 | $386,850 | $341,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,253 | 2,254 | 2,424 | 2,505 | 1,910 |
| Accrued Expenses | 8,568 | 5,810 | 7,387 | 6,831 | 9,216 |
| Other current liabilities | N/A | N/A | N/A | 25 | 30 |
| TOTAL | $11,545 | $10,609 | $13,033 | $14,471 | $17,904 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 94 | 972 | 1,705 | 3,648 | 5,340 |
| Other Non-Current Liabilities | 22,190 | 22,612 | 23,025 | 23,431 | 23,820 |
| TOTAL | $22,190 | $22,612 | $23,025 | $23,431 | $24,127 |
| Total Liabilities | $33,735 | $33,221 | $36,058 | $37,902 | $42,031 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,165 | 51,851 | 51,660 | 46,168 | 46,139 |
| Common Shares | 52 | 51 | 46 | 46 | 42 |
| Retained earnings | -189,482 | -183,523 | -168,763 | -157,005 | -145,437 |
| Other shareholders' equity | -1,616 | -524 | 665 | -1,175 | -1,060 |
| TOTAL | $657,677 | $655,763 | $344,349 | $348,948 | $299,469 |
| Total Liabilities And Equity | $691,412 | $688,984 | $380,407 | $386,850 | $341,500 |